FCM
EIDX

Flinton Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Flinton Capital Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
2019
Q2 		$100K Hold
2019
Q1 		$76K Hold
2018
Q4 		$44K Sell
2018
Q3 		$149K Buy
2018
Q2 		$110K Buy